证券研究报告 金融行业周报 ——中金公司重组预案出炉，中央财办进一步明确政策导向 证券分析师 袁喆奇S1060520080003（证券投资咨询） 李冰婷S1060520040002（证券投资咨询） 许 淼S1060525020001（证券投资咨询） 研究助理 李灵琇S1060124070021（一般证券业务） 请务必阅读正文后免责条款 2025年12月22日 1 1、中金公司"三合一"重大资产重组预案出炉。12月17日晚间，中金公司与东兴证券、信达证券同步披露重大资产重组预 案，中金公司换股吸收合并两家公司的交易定价与方案明晰。3家上市券商A股股票均于12月18日开市起复牌。本次合并后主 体有望在发挥原有中金公司投资银行、私募股权投资、机构业务、资产管理和国际化业务优势的基础上，吸收信达证券和东 方证券在企业纾困、并购重整、区域布局、零售客户上的特色资源，新主体资本金得到进一步补充的情况下，有望充分发挥 AMC产业优势和股东赋能，实现汇金系"投行+AMC资源"的深度协同，加快一流投资银行和投资机构建设进程。 2、中央财办详解2025年中央经济工作会议精神。12月16日，中央财办有关负责同志详解年中央经济工作会 ...

Investment Rating - The report maintains a "Strong Buy" rating for the oil and petrochemical sector [1]. Core Viewpoints - Progress in peace negotiations between Russia and Ukraine has led to a decrease in oil prices, reflecting a retreat from geopolitical premiums [6]. - The U.S. labor market shows signs of weakness, with a reduction of 41,000 jobs in October and November combined, and the unemployment rate rising to 4.6%, the highest since October 2021 [6]. - The CPI for November recorded a year-on-year increase of 2.7%, below market expectations, suggesting potential easing of inflationary pressures [6]. - In the fluorochemical sector, the 2026 refrigerant quotas are set to increase, and government subsidies for home appliances are expected to continue, supporting demand [6]. - The automotive sector is experiencing sustained growth due to government incentives for vehicle scrappage and replacement [6]. Summary by Sections Oil and Petrochemicals - The report highlights the successful progress in peace talks between Russia and Ukraine, which has contributed to a decline in oil prices, with WTI and Brent crude futures dropping by 1.67% and 1.09% respectively [6]. - The U.S. refining capacity is recovering post-maintenance, with a slight reduction in commercial crude oil inventories, while gasoline and jet fuel stocks are increasing [6]. - The report notes that domestic oil companies are diversifying their oil and gas sources to reduce sensitivity to international oil price fluctuations [7]. Fluorochemicals - The 2026 production quotas for HFCs have been announced, with a total of 797,845 tons, an increase of 5,963 tons from the previous year [6]. - The demand for refrigerants is expected to improve due to ongoing government subsidies and a strong automotive market [6]. Semiconductor Materials - The semiconductor materials sector is experiencing a positive inventory destocking trend, with improving fundamentals in the end market [7]. - The report suggests that the upward cycle in semiconductor materials, combined with domestic substitution, may lead to further price increases [7].

Core Viewpoints - The A-share market experienced a rebound after an initial decline, with broad-based ETFs seeing significant inflows, stabilizing market expectations. The Shanghai Composite Index rose by 0.03%, while the Wande Microplate Index and the CSI Dividend Index increased by 3.0% and 1.0%, respectively. The retail trade sector led the gains with an approximate increase of 6.7% [2][12][15]. Economic Data Summary - In November, the high-tech industry showed accelerated production growth, while retail sales and investment growth slowed down. The industrial value added increased by 4.8% year-on-year, with high-tech industries rebounding to 8.4%. However, retail sales growth fell to 1.3%, and fixed asset investment decreased by 2.6% [3][4]. Policy Tracking Summary - Recent policies include the introduction of a draft regulation for insurance company asset-liability management, which aims to enhance long-term operational stability and risk management. The regulation consolidates previous requirements and sets clear regulatory indicators [5]. Market Performance Summary - The A-share market showed mixed performance, with 19 out of 31 sectors achieving positive returns. The consumer sector and non-bank financials performed well, while sectors like machinery and electronics lagged behind. The dairy index led the concept indices with an increase of approximately 11.3% [12][15][16].

Investment Rating - The industry investment rating is "Outperform the Market" (预计6个月内，行业指数表现强于市场表现5%以上) [32] Core Insights - The National Healthcare Security Administration issued the "Guidelines for the Establishment of Pricing Projects for Pathological Medical Services (Trial)," which aims to systematically reshape existing pathological pricing projects, focusing on biopsy sampling, sample processing, slice replication, pathological staining, and diagnosis, establishing 28 pricing projects, 3 additional charges, and 2 expansion items. This refined pricing is expected to promote high-quality development in pathology and create new scenarios for the application of artificial intelligence-assisted technologies [4] - The guidelines will standardize the charging for digital pathological slices, solidifying the data foundation for large-scale applications of new scenarios. It includes "providing digital images of pathological slices" as an essential item for various pathological services, reflecting the costs of related resource consumption in pricing [4] - The guidelines also explore suitable forms to respond to the charging demands of artificial intelligence assistance, promoting the early application of AI in the pathology field by including "AI-assisted diagnosis" as an expansion item in the pricing structure [4] - The establishment of separate pricing projects for pathological diagnosis and sample testing emphasizes the value of technical services and supports precise medication guidance [4] Summary by Sections Investment Strategy - The report suggests focusing on innovative pharmaceutical companies with rich pipeline layouts, such as Heng Rui Medicine, BeiGene, and China National Pharmaceutical Group. It also highlights companies with significant single-product potential and price revaluation prospects, such as 3SBio, Kaineng Technology, and Qianhong Pharmaceutical. Additionally, it recommends companies leading in cutting-edge technology platform layouts, such as Dongcheng Pharmaceutical, Yuanda Pharmaceutical, and Kelun-Biotech [6] - In the CXO sector, it notes that R&D investment in pharmaceuticals is steadily increasing, and the innovation environment is expected to improve, suggesting attention to companies like WuXi AppTec, WuXi Biologics, and Boteng Co. [6] - For upstream companies, it indicates that quality enterprises are entering a harvest period with overseas layouts, recommending attention to Aopumai, Baipusais, and Baiyao [6] - In the medical device sector, it mentions that ongoing procurement will continue to advance, with equipment companies gradually digesting channel inventory, suggesting attention to Mindray Medical, United Imaging, and Kaili Medical [6] Industry News - The report highlights several key developments in the industry, including Takeda's TYK2 drug achieving positive results in Phase III studies, Baiyatai's anti-VEGF monoclonal antibody application for market approval, Sanofi's innovative therapy for hypertrophic cardiomyopathy receiving domestic approval, and Enhertu (Trastuzumab Deruxtecan) gaining FDA approval for a new indication [8][12][15][16]

Investment Rating - The industry investment rating is "Outperform the Market," indicating that the industry index is expected to perform better than the market by more than 5% over the next six months [8]. Core Insights - Micron Technology's FY26Q1 financial results exceeded expectations, with Non-GAAP revenue reaching $13.64 billion, a year-on-year increase of 57% and a quarter-on-quarter increase of 21%. Non-GAAP net profit was $5.48 billion, up 169% year-on-year and 58% quarter-on-quarter [3][6]. - The storage industry is experiencing a strong upward cycle driven by AI, with significant demand for storage products expected to continue until 2026 due to supply constraints. The overall trend is for both volume and price of storage products to rise [5][6]. - The company's DRAM business revenue increased by 69% year-on-year to $10.8 billion, accounting for 79% of total revenue, with an average selling price (ASP) up by 20% quarter-on-quarter [5][6]. - The cloud data business achieved a record revenue of $5.3 billion, with a notable gross margin increase of 15 percentage points year-on-year [6]. - The company anticipates FY26Q2 revenue to be in the range of $18.3 billion to $19.1 billion, representing a year-on-year increase of 132% and a quarter-on-quarter increase of 37% [6]. Summary by Sections Financial Performance - Micron's Non-GAAP revenue for FY26Q1 was $13.64 billion, with a gross margin of 56.8%, up 17 percentage points year-on-year and 11 percentage points quarter-on-quarter [3][6]. - The company expects a gross margin of 68% for FY26Q2, an increase of 30.1 percentage points year-on-year [6]. Market Demand - The demand for high-performance and high-capacity storage is significantly increasing due to the acceleration of AI data center construction [6][7]. - The company is actively developing advanced products, including HBM and high-performance SSDs, to meet this demand [6][7]. Future Outlook - The storage supply is expected to remain tight until 2026, leading to sustained price increases in storage products [5][6]. - The company is focusing on expanding its product offerings and improving production efficiency to capitalize on the growing market demand [6][7].

2025年12月19日 请务必阅读正文后免责条款 摘要 证券研究报告 【平安证券】震荡寻微光 ——2026年公募REITs年度策略报告 证券分析师 刘 璐 投资咨询资格编号：S1060519060001 陈蔚宁 投资咨询资格编号：S1060524070001 25年REITs供需均强，估值提升。截至11月28日（下同），25年REITs指数上涨7%，跑赢债券、跑输权益，与历史年度涨幅相比亦居中位。基本面 变动不大，延续"稳定好于周期"的特点。供需方面，供给攀升，二级市场解禁是重要的供给来源；需求方面，受益于资产荒、上半年牛市，投资 者需求也有所升温。投资者对REITs接受度提升，全市场IRR下行1.47pct至4.01%，IRR-10Y国债利差压缩至217BP。 25年REITs市场的三条策略主线：参与一级发行、消费、基于估值的板块切换。主线一，一级认购策略收益丰厚。25年上市的新项目一二级现金分 派率差平均为1.34pct，明显高于24年水平；新行业分派率较可比资产高约3pct。一级网下打新、参与战配在25年的期望收益率可达到29%、34%； 市政、新型基础设施两个新行业上市以来涨幅超40%。主线二，24Q ...

Revenue and Expenditure Trends - Public fiscal revenue growth for the first 11 months of 2025 was 0.8% year-on-year, maintaining the previous month's pace[3] - Public fiscal expenditure growth for the same period was 1.4%, a decrease of 0.6 percentage points from the previous month[3] - The deficit utilization rate for the first account was 62.2%, which is 9.2 percentage points lower than the average of the past three years[3] Tax Revenue Insights - National tax revenue growth for the first 11 months was 1.80%, an increase of 0.1 percentage points from the previous month[3] - Non-tax revenue saw a decline of 3.7%, down 0.6 percentage points from the previous month, influenced by a high base from last year[3] - Tax revenue growth has been positive for 8 consecutive months, reaching 2.8% in November, despite a slight decline from the previous month[3] Fiscal Spending Focus - Science and technology expenditure grew by 7.9% year-on-year, while social welfare spending increased by 5.4%, both outpacing overall fiscal expenditure growth[3] - Infrastructure spending remained weak, with a year-on-year decline of 7.7%, down 1.2 percentage points from the previous month[3] Government Fund Performance - Government fund revenue decreased by 4.9% year-on-year, while expenditure increased by 13.7%, showing a marginal decline from the previous month[3] - In November, government fund revenue fell by 15.8%, but expenditure grew by 2.8%, indicating stronger expenditure performance[3] Overall Fiscal Outlook - The cumulative year-on-year growth rate of broad fiscal revenue fell by 0.5 percentage points, while expenditure growth decreased by 0.7 percentage points, suggesting less urgency for short-term fiscal stimulus[3] - The central economic work conference emphasized accelerating fund disbursement to promote actual spending and physical work volume[3] Risk Factors - Potential risks include underperformance of growth stabilization policies, escalation of geopolitical conflicts, and greater-than-expected overseas economic downturns[11]

Investment Rating - The industry investment rating is "Outperform the Market" [7] Core Viewpoints - The merger plan of CICC, Dongxing Securities, and China Cinda has been implemented, enhancing the comprehensive financial service capabilities [3] - The merger is expected to result in CICC's operating revenue of approximately 27.4 billion yuan and total assets reaching 1.01 trillion yuan, ranking it fourth among listed securities firms [3] - The ongoing supply-side reform in the financial sector is expected to improve the competitive landscape and service capabilities of the industry [4] Summary by Sections Merger Details - On December 17, CICC, Dongxing Securities, and China Cinda announced their share swap merger plan [2] - The share swap ratios are 0.4373 shares of CICC for each share of Dongxing Securities and 0.5188 shares for each share of China Cinda [3] Financial Projections - Post-merger, CICC's net profit is projected to reach 9.52 billion yuan, making it the sixth largest among listed securities firms [3] - The industry is expected to see significant growth in 2025 due to ongoing capital market reforms and the continuous influx of long-term funds [4] Market Positioning - The merger is part of a broader trend of consolidation in the securities industry, aimed at creating "first-class investment banks and investment institutions" [3][4] - Major shareholders have committed to a 36-month lock-up period for their shares acquired in the merger [3]

Group 1: Global Technology Competition - The global technology competition is increasingly defined by the US-China rivalry, with China narrowing the gap in fields like semiconductors and artificial intelligence[7] - In 2025, AI-related investments contributed approximately 6.8% to the US GDP, with a notable 0.92 percentage point contribution to year-on-year GDP growth in Q2[12] - The capital expenditure of the top seven US tech companies (MAG7) reached nearly $267 billion in 2025, a 67.7% increase year-on-year, accounting for about 27% of total S&P 500 capital expenditure[9] Group 2: International Trade and Economic Confidence - In 2025, China's direct exports to the US decreased to 11.3% of total exports, down from 14.7% in 2024, indicating a shift in trade dynamics[21] - The Chinese government effectively countered US tariffs, showcasing its industrial strength and market size, with the Wind All A index rising by 22.2% in 2025[19] - China's dominance in rare earth processing, with a 58% share of global production capacity, underpins its strategic response to international trade conflicts[20] Group 3: Economic Transition and Structural Changes - The "new new three" categories—robots, artificial intelligence, and innovative drugs—are set to lead China's industrial upgrade, reflecting a shift towards high-end manufacturing[27] - By 2024, the "three new" industries accounted for about 18% of GDP, while the real estate and construction sectors' share fell from 15.3% in 2020 to 12.9%[27] - In the first ten months of 2025, China's industrial robot production increased by 28.8% year-on-year, with exports growing by 61.5%[28] Group 4: Policy and Market Dynamics - The Chinese government is focusing on "anti-involution" policies to promote rational market competition, with significant measures announced in 2025 to eliminate local protectionism[35] - Fiscal policy in 2025 emphasized "stabilizing growth" through increased central leverage, with net fiscal injections contributing 76% to new M2 growth in the first three quarters[3]

Investment Rating - The industry investment rating is "Outperform the Market" (maintained) [1] Core Viewpoints - The central economic work conference emphasizes stabilizing the real estate market, leading to increased market expectations for policy changes. It is deemed necessary to lower mortgage rates to enhance home buying attractiveness, with a focus on subsequent changes in mortgage rates [2][3] - The current domestic adjustment in volume and price is approaching that of previous overseas cycles, with the adjustment duration slightly shorter than overseas. A simple comparison suggests that the industry may reach a bottom and stabilize between the second half of 2026 and 2027 [2] - The decline in Hong Kong's Hibor in Q2 2025 is expected to lead to a decrease in mortgage rates, which could be a crucial factor for regional market stabilization. If mortgage rates in 2026 are lowered more than expected, it may catalyze a similar recovery as seen in Hong Kong [2] - Investment recommendations focus on three main lines: 1) Real estate companies with light historical burdens and strong product capabilities, such as China Resources Land and China Overseas Development, are expected to benefit from the "good housing" initiative; 2) Hong Kong real estate firms benefiting from the stabilization of the Hong Kong market; 3) Companies with stable cash flow and dividends, such as China Resources Vientiane Life and Poly Property [2] Policy Summary - The pilot program for commercial real estate REITs has been initiated, expanding the scope to include urban renewal facilities, hotels, and sports venues, aiding in the transformation of the real estate sector [3][5] - The central economic work conference aims to stabilize the real estate market and reduce inventory, with a focus on boosting residents' willingness to purchase homes. It is expected that mortgage rate reductions and the loosening of housing restrictions will continue [5][6] Financial Summary - In November 2025, the M2 growth rate was 8%, with a slight decline in the growth rate compared to the previous month. The social financing stock growth rate remained stable at 8.5% [12] - The new personal housing loan rate in Q3 2025 was 3.07%, indicating potential room for further mortgage rate reductions [16] Market Performance - In November, the average daily transaction volume of new homes in 50 key cities decreased by 43.1% year-on-year, while the average daily transaction volume of second-hand homes in 20 key cities decreased by 27.8% year-on-year [20] - The average land supply in 100 cities in November was 31 million square meters, a 130% increase month-on-month, while the average transaction area was 12 million square meters, showing a slight decrease [27] Company Performance - In November 2025, the sales amount of the top 100 real estate companies decreased by 36.8% year-on-year, with a cumulative sales amount decline of 18.8% for the first 11 months [35] - The average land acquisition sales ratio for the top 50 real estate companies was 19% for sales amount and 31% for sales area, both showing a decrease compared to the previous month [39] Stock Market Performance - The real estate sector index fell by 2.81% in November, underperforming the CSI 300 index, which fell by 2.46%. As of December 15, 2025, the real estate sector's PE (TTM) was 58.54 times, placing it in the 94.24 percentile of the past five years [40][43]